Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of CCI-779 as an antineoplastic agent

Use of CCI-779 as an antineoplastic agent

US Patent 7189735 · Granted Mar 13, 2007

Estimated economic value: $114,316,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of a receptor-type kinase modulator for treating polycystic kidney disease2018
Use of a receptor-type kinase modulator for treating polycystic kidney disease2016
Anti-tumor activity of CCI-779 in papillary renal cell cancer2014
Anti-tumor activity of CCI-779 in papillary renal cell cancer2014
Substituted 3-cyanoquinolines2011
Use of CCI-779 as an antineoplastic agent2010
Use of CCI-779 as an antineoplastic agent2010
Use of CCI-779 as an antineoplastic agent2010
Use of CCI-779 as an antineoplastic agent2010
Use of CCI-779 as an antineoplastic agent2010
Method for the treatment of polycystic kidney disease2009
Method of potentiating chemotherapy and treating solid tumors2008